ClinicalTrials.gov
ClinicalTrials.gov Menu

Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01176305
Recruitment Status : Completed
First Posted : August 6, 2010
Last Update Posted : August 6, 2010
Sponsor:
Information provided by:
Hillerod Hospital, Denmark

Brief Summary:
The purpose of this study is to describe the incidence of thromboembolic events in relation to pregnancy and when in pregnancy and the puerperal period.

Condition or disease
Venous Thromboembolism

Detailed Description:

Venous thromboembolism (VTE) still causes maternal death in the western world. The purpose of this study is to estimate the relative and absolute risk of VTE at different gestational ages in pregnant women compared to non-pregnant women.

All Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives are included.Non-pregnant women are controls.


Study Type : Observational
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Postpartum Care

Group/Cohort
Danish Women 15 to 49 years old.
Free of previous VTE and current use of oral contraceptives.



Primary Outcome Measures :
  1. Absolute incidence of thromboembolic event


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 50 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Danish Women 15 to 49 years old in the period January 1995 through December 2005, free of previous VTE and current use of oral contraceptives.
Criteria

Inclusion Criteria:

  • Danish woman at 15 to 49 years old in the period January 1995 through December 2005.
  • Free of previous VTE and current use of oral contraceptives.

Exclusion Criteria:

  • Previous VTE or current use of oral contraceptives.

Responsible Party: Thomas Bergholt, Hillerod Hospital, Gynecolocical-Obstetrical department
ClinicalTrials.gov Identifier: NCT01176305     History of Changes
Other Study ID Numbers: RAV1
First Posted: August 6, 2010    Key Record Dates
Last Update Posted: August 6, 2010
Last Verified: October 2009

Keywords provided by Hillerod Hospital, Denmark:
Thromboembolic event

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases